M.B., B.S., B.Sc., M.Med. (Ophth.Sc.), F.R.A.N.Z.C.O.
Dr Li-Anne Lim is an ocular oncologist, cataract surgeon and general ophthalmologist. She has a special interest in managing patients with cancer of the eye including adult eye cancer such as melanoma, lymphoma and conjunctival tumours, and paediatric eye cancer such as retinoblastoma as well as simulating lesions.
Li-Anne graduated from the University of NSW medical school and also completed a Masters degree from the University of Sydney in Clinical Ophthalmology with a treatise on conjunctival melanoma. She spent one year at the Henry C. Witelson Ocular Pathology Laboratory, McGill University, Montreal, Canada following which she completed her ophthalmology training at Sydney Eye Hospital, which included 6 months as the Professorial Senior Ophthalmology Registrar. As a recipient of the Normal Rose Travelling Scholarship and RANZCO travelling scholarship, she pursued further subspecialty fellowship training at Wills Eye Hospital, Philadelphia, USA. Training under leaders in the field Drs Carol and Jerry Shields, Li-Anne exclusively dealt with the diagnosis and management of intraocular and periocular malignant and benign tumours, and simulating lesions. Experience at this high volume, tertiary referral centre, has allowed Li-Anne to gain expertise in the clinical management of eye cancers, research, and new imaging and therapeutic technologies.
Li-Anne is a Clinical Senior Lecturer at the University of Sydney and has published in peer-reviewed journals and presented at international conferences. She is a member of the International Society of Ocular Oncology and is involved in the Multi-institutional Ocular Oncology Multidisciplinary Meeting at The Kinghorn Cancer Centre, St Vincent’s Hospital. Together with Dr Michael Giblin, the first ophthalmologist to undergo fellowship training in Ocular Oncology in Australia, Li-Anne is dedicated to providing the highest standard of care for patients with eye cancer. Dr Lim is also an experienced general ophthalmologist.